Sectral and Lung disorder - a phase IV clinical study of FDA data

Summary:

Lung disorder is reported as a side effect among people who take Sectral (acebutolol hydrochloride), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Omeprazole, and have Osteoporosis.

The phase IV clinical study analyzes which people have Lung disorder when taking Sectral. It is created by eHealthMe based on reports of 3,508 people who have side effects when taking Sectral from the FDA, and is updated regularly.

What is Sectral?

Sectral has active ingredients of acebutolol hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 3,548 Sectral users. Check the latest studies of Sectral.

What is Lung disorder?

Lung disorder (lung disease) is found to be associated with 1,798 drugs and 1,787 conditions by eHealthMe. Check the latest studies of Lung disorder.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

3,508 people reported to have side effects when taking Sectral.
Among them, 42 people (1.2%) have Lung disorder.

Among these 42 people:

How long have people been on Sectral when they have Lung disorder? *

What is the gender of people who have Lung disorder when taking Sectral? *

female: 62.5 %
male: 37.5 %

What is the age of people who have Lung disorder when taking Sectral? *

What are other drugs people take besides Sectral? *

What are other side effects people have besides Lung disorder? *

Fever: 9 people, 21.43%
Acute Kidney Failure: 6 people, 14.29%
Sepsis (a severe blood infection that can lead to organ failure and death): 6 people, 14.29%
Haemoglobin Decreased: 5 people, 11.90%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 5 people, 11.90%
Respiratory Distress (difficulty in breathing): 3 people, 7.14%
Thrombocytopenia (decrease of platelets in blood): 3 people, 7.14%
Cough: 3 people, 7.14%
Cardio-Respiratory Arrest (sudden dysfunction of heart and lungs): 3 people, 7.14%
Myocardial Ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased): 2 people, 4.76%

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 5 people, 11.90%
Anaemia (lack of blood): 4 people, 9.52%
Diabetes: 4 people, 9.52%
Hyperlipidaemia (presence of excess lipids in the blood): 4 people, 9.52%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 7.14%
Cardiac Disorder: 3 people, 7.14%
Depression: 3 people, 7.14%
Pain: 3 people, 7.14%
Ventricular Tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart): 2 people, 4.76%
Hyperchlorhydria (gastric acid levels are higher in stomach): 2 people, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Sectral and have Lung disorder?

- Check whether Lung disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Sectral:

Sectral (3,548 reports)

Lung disorder treatments and more:

Lung disorder (66,567 reports)

Browse all side effects of Sectral:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Lung disorder:

Lung disorder (1,798 drugs)

Browse all the conditions that are associated with Lung disorder:

Lung disorder (1,787 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on acebutolol hydrochloride (the active ingredients of Sectral) and Sectral (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.